FDA warns about azithromycin in some cancers

The FDA has issued a safety alert warning against long-term use of azithromycin to prevent bronchiolitis obliterans syndrome in patients with blood or lymph node cancers. Also today, four syndromes suggest life-threatening PVL-positive Staphylococcus aureus infection, asthma medication ratio identifies high-risk pediatric patients, and new MS criteria may create more false positives. Listen to the MDedge Daily News for today’s top news.